Screener
Climb Bio, Inc. CLYM Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Climb Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The source filing: Climb Bio, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210357
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $8,356 | $35,685 |
| Short-term marketable securities | 101,208 | 65,395 |
| Prepaid expenses and other current assets | 3,840 | 4,769 |
| Total current assets | 113,404 | 105,849 |
| Long-term marketable securities | 36,741 | 59,572 |
| Operating lease right-of-use assets | 447 | 505 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Climb Bio, Inc.'s short-term investments?
- Climb Bio, Inc. (CLYM) reported short-term investments of $101.21M in Q1 2026.
- How has Climb Bio, Inc.'s short-term investments changed year-over-year?
- Climb Bio, Inc.'s short-term investments increased by 46.6% year-over-year, from $69.04M to $101.21M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Climb Bio, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude